Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)
Meiko Nishimura, Takahiro Kogawa, Keiji Sugiyama, Yukinori Ozaki et autres
jp (code pays fourni par la source)
0 citations
Breast Cancer Research and Treatment